tiprankstipranks
NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
US Market
Holding NRBO?
Track your performance easily

NeuroBo Pharmaceuticals (NRBO) Stock Investors

329 Followers
Based on 769,002 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRBO
On average, investors allocate 0.00% of their portfolios to NRBO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 769,002 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRBO

2.0%
Last 7
Days
10.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRBO, out of 769,002 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRBO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,689 investors who made their portfolios public
The table shows changes in NRBO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRBO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
4.47%
+1.52%
+3.74%
51.87B
Technology
Viking Therapeutics
4.54%
-0.83%
+5.78%
5.53B
Healthcare
Plug Power
5.21%
-1.12%
-0.73%
1.70B
Industrials
DraftKings
5.47%
-1.79%
+0.46%
35.08B
Consumer Cyclical
XPeng, Inc. ADR
5.53%
-1.27%
-1.09%
12.05B
Consumer Cyclical
Enphase Energy
4.55%
-0.16%
+3.30%
8.04B
Technology
Riot Platforms
5.30%
+0.10%
+2.02%
4.11B
Financial
CVS Health
3.99%
-0.20%
-0.76%
66.93B
Healthcare
Marathon Digital Holdings
5.64%
+0.76%
+5.08%
6.78B
Financial
RTX
4.15%
-0.21%
+6.62%
157.77B
Industrials
Based on the activity of 769,002 active portfolios
Open your Smart Portfolio

NRBO Investor Analysis

NRBO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
12.2%
of NRBO holders
are under 35
Average Segment Performance
Average P/E Ratio29.47
Beta10.82
Dividend Yield99.38%
NRBO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.5%
of NRBO holders
are between 35–55
Average Segment Performance
Average P/E Ratio26.86
Beta20.87
Dividend Yield46.37%
NRBO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
29.3%
of NRBO holders
are over 55
Average Segment Performance
Average P/E Ratio25.26
Beta9.51
Dividend Yield77.60%
Overview of age group and performance of NRBO stock investors
See who invests in NRBO according to age group and performance.

FAQ

How many retail Investors hold NRBO?
<0.1% of TipRanks' retail investors hold NRBO in their portfolios.
    What is NRBO Investor Sentiment?
    NRBO’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NRBO in the last 7 days?
      ▼ 2.0% of TipRanks' retail investors changed their holding of NRBO in the last 7 days.
        What percentage of retail investors changed their holding of NRBO in the last 30 days?
        ▼ 10.0% of TipRanks' retail investors changed their holding of NRBO in the last 30 days.
          What is the average age of retail investors who hold NRBO?
          The average age of NRBO Holders is between 35–55.
            What other stocks have NRBO investors also bought?
            NRBO Investors also bought SQ, VKTX, PLUG, DKNG, XPEV, ENPH, RIOT, CVS, MARA, RTX.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              BAXBaxter International
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis